Showing results (61-70 of 75) with videos related to
Sort By:
Pageof 8
British Journal of Cancer|November 27, 2001
Reduced expression of BAX is associated with poor prognosis in patients with epithelial ovarian cancer: a multifactorial analysis of TP53, p21, BAX and BCL-2M Schuyer, M E van der Burg, S C Henzen-Logmans, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 4, 2006
Reasons for failure to identify positive sentinel nodes in breast cancer patients with significant nodal involvementA Y de Kanter, M B E Menke-Pluijmers, S C Henzen-Logmans, et al.Thorax|May 1, 1983
Neurone-specific enolase and S-100: new markers for delineating the innervation of the respiratory tract in man and other mammalsM N Sheppard, S S Kurian, S C Henzen-Logmans, et al.Journal of Cancer Research and Clinical Oncology|January 1, 1992
Occurrence of epidermal growth factor receptors in benign and malignant ovarian tumors and normal ovarian tissues: an immunohistochemical studyS C Henzen-Logmans, M E van der Burg, J A Foekens, et al.International Journal of Cancer|June 17, 1999
Prognostic value of CD44 variant expression in primary breast cancerJ A Foekens, P Dall, J G Klijn, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 18, 2000
Controlled introduction of the sentinel node biopsy in breast cancer in a multi-centre setting: the role of a coordinator for quality controlA Y de Kanter, A N van Geel, M A Paul, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Prognostic significance of cathepsins B and L in primary human breast cancerJ A Foekens, J Kos, H A Peters, et al.The Journal of Steroid Biochemistry and Molecular Biology|December 20, 1990
Prognostic value of pS2 protein and receptors for epidermal growth factor (EGF-R), insulin-like growth factor-1 (IGF-1-R) and somatostatin (SS-R) in patients with breast and ovarian cancerJ A Foekens, W L van Putten, H Portengen, et al.FEBS Letters|November 6, 1998
Loss of imprinting of IGF2 and not H19 in breast cancer, adjacent normal tissue and derived fibroblast culturesC E van Roozendaal, A J Gillis, J G Klijn, et al.British Journal of Cancer|January 1, 1997
The prognostic significance of expression of the multidrug resistance-associated protein (MRP) in primary breast cancerK Nooter, G Brutel de la Riviere, M P Look, et al.Pageof 8